🇧🇷Brazil

Risco de Recusa de Cobertura de Plano de Saúde por Violação de Dados Sensíveis

2 verified sources

Definition

Procon investigation identified that unauthorized CPF data capture exposes consumers to insurance coverage denial scenarios. Example: A consumer purchasing blood pressure medication for a parent; if database is breached, records could be used by health insurers to deny coverage on grounds of pre-existing condition non-disclosure. This cascading liability affects both end consumer and pharmacy reputation.

Key Findings

  • Financial Impact: Per-customer litigation cost: R$ 10,000–R$ 50,000; churn impact: 2–5% customer base loss annually; class action risk: R$ 5,000,000+.
  • Frequency: Triggered upon data breach event; systemic exposure across all customer base stored in pharmacy loyalty databases.
  • Root Cause: Inadequate data governance; lack of breach incident response protocol; absence of customer communication controls on sensitive medication data.

Why This Matters

The Pitch: Brazilian pharmacy chains risk customer churn and litigation costs when personal medication histories are compromised. Secure, consent-compliant data handling prevents coverage denial scenarios and protects customer relationships.

Affected Stakeholders

Customer Service, Risk Management, Legal/Compliance, Communications

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Multa por Violação de LGPD e Privacidade do Consumidor

R$ 8,497,500.00 (confirmed fine); potential industry exposure: R$ 50,000–R$ 3,000,000 per administrative proceeding depending on scale and intent.

Penalidades por Não-Conformidade ao SNGPC (Portaria 344/1998)

LOGIC-based estimate: Typical ANVISA administrative fines for non-compliance range R$ 5,000–R$ 50,000 per violation; larger networks face R$ 100,000+ for systemic SNGPC failures. Operational costs from license suspensions or revocation: loss of controlled-substance revenue (15–30% of pharmacy revenue), estimated R$ 50,000–R$ 500,000+ per pharmacy per month during suspension.

Atraso Operacional por Registro Manual no SNGPC (Sistema Nacional de Gerenciamento de Produtos Controlados)

LOGIC-based estimate: 2–5 minutes per controlled-substance transaction × 20–50 controlled transactions/day per pharmacy × 22 working days/month = 14.6–110 hours/month of technician time (R$ 880–R$ 6,600/month at R$ 60/hour blended cost). For pharmacy networks with 50+ locations: R$ 44,000–R$ 330,000/month in lost labor capacity.

Risco de Desvio e Furto de Medicamentos Controlados por Falta de Rastreabilidade em Tempo Real

LOGIC-based estimate: Average shrinkage rate 1–3% of controlled-substance inventory. For a mid-sized pharmacy (R$ 100,000/month in controlled-substance revenue): R$ 1,000–R$ 3,000/month loss. For pharmacy network (50 locations): R$ 50,000–R$ 150,000/month undetected shrinkage. Annual impact: R$ 600,000–R$ 1.8M per network.

Erros de Decisão por Falta de Visibilidade em Tempo Real sobre Estoque de Medicamentos Controlados

LOGIC-based estimate: 2–5% inventory waste (expiration/spoilage) on R$ 100,000/month controlled-substance revenue = R$ 2,000–R$ 5,000/month. 5–10% stock-out-driven lost sales = R$ 5,000–R$ 10,000/month forgone margin. Combined: R$ 7,000–R$ 15,000/month per pharmacy. Network (50 locations): R$ 350,000–R$ 750,000/month. Annual: R$ 4.2M–R$ 9M.

Perda por Vencimento de Medicamentos (Product Expiration Waste)

Estimated: R$ 2,000–25,000 annually per pharmacy (2–5% of typical inventory value of R$ 100,000–500,000). Pharmacy chains with 10+ locations: R$ 20,000–250,000+ annually.

Request Deep Analysis

🇧🇷 Be first to access this market's intelligence